Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: J Alzheimers Dis. 2017;58(2):401–411. doi: 10.3233/JAD-160965

Table 5c.

Summary of the RADD-2 Total Score (mITT Population)

RADD Total Score (calculated) Placebo
(N=6)
ELND005 250 mg BID
(N=12)
ELND005 250 mg QD
(N=4)

Baseline
 Mean (SD) 62.2 (9.8) 58.7 (10.2) 58.0 (15.6)
 Median 66.5 61.5 63.0
 Range 49.0–73.0 43.0–70.0 36.0–70.0

Week 4
 Mean (SD) 62.8 (10.3) 59.1 (11.5) 64.3 (13.5)
 Median 65.0 62.5 70.5
 Range 49.0–75.0 35.0–72.0 44.0–72.0

Week 4 CFB
 Mean (SD) 0.7 (2.3) 0.4 (4.3) 6.3 (4.6)
 Median 0.5 1.0 5.5
 Range –3.0–4.0 −8.0–8.0 2.0–12.0